FDA Nominee Hedges On Job Cuts, Abortion Drug In Hearing
By Mark Payne · March 6, 2025, 1:56 PM EST
The nominee to lead the U.S. Food and Drug Administration, Dr. Marty Makary, repeatedly hedged about whether he would reconvene a flu vaccine committee, maintain access to the abortion drug mifepristone...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login